ALYSSA WEBB: Open Payments
NPI 1538543145 · WINFIELD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 11 payments from 7 companies in 2025. Trend: 2023 $132 · 2024 $150 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $102 |
| Novo Nordisk Inc | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: GEMTESA, Wegovy, Kerendia, VRAYLAR, Cologuard Collection Kit, XIFAXAN.
Industry payments across AL — which companies pay providers there.
